PDS Biotechnology Corp. (PDSB)
0.2947
-0.01
(-1.77%)
USD |
NASDAQ |
Sep 09, 12:20
PDS Biotechnology Market Cap : 16.48M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 16.78M |
| September 04, 2026 | 12.30M |
| September 03, 2026 | 12.30M |
| September 02, 2026 | 11.86M |
| September 01, 2026 | 11.41M |
| August 31, 2026 | 11.97M |
| August 28, 2026 | 11.79M |
| August 27, 2026 | 12.19M |
| August 26, 2026 | 12.48M |
| August 25, 2026 | 12.39M |
| August 24, 2026 | 12.12M |
| August 21, 2026 | 12.22M |
| August 20, 2026 | 11.68M |
| August 19, 2026 | 11.22M |
| August 18, 2026 | 11.63M |
| August 17, 2026 | 12.33M |
| August 14, 2026 | 12.90M |
| August 13, 2026 | 13.04M |
| August 12, 2026 | 13.53M |
| August 11, 2026 | 14.36M |
| August 10, 2026 | 40.81M |
| August 07, 2026 | 43.27M |
| August 06, 2026 | 41.70M |
| August 05, 2026 | 40.56M |
| August 04, 2026 | 40.19M |
| Date | Value |
|---|---|
| August 03, 2026 | 39.87M |
| July 31, 2026 | 38.30M |
| July 30, 2026 | 39.02M |
| July 29, 2026 | 37.37M |
| July 28, 2026 | 38.55M |
| July 27, 2026 | 38.66M |
| July 24, 2026 | 38.03M |
| July 23, 2026 | 39.10M |
| July 22, 2026 | 39.94M |
| July 21, 2026 | 42.42M |
| July 20, 2026 | 40.04M |
| July 17, 2026 | 41.02M |
| July 16, 2026 | 39.70M |
| July 15, 2026 | 41.64M |
| July 14, 2026 | 41.97M |
| July 13, 2026 | 41.59M |
| July 10, 2026 | 43.20M |
| July 09, 2026 | 43.94M |
| July 08, 2026 | 46.04M |
| July 07, 2026 | 46.61M |
| July 06, 2026 | 47.23M |
| July 02, 2026 | 47.62M |
| July 01, 2026 | 48.78M |
| June 30, 2026 | 49.18M |
| June 29, 2026 | 50.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.777B |
| Alnylam Pharmaceuticals, Inc. | 34.15B |
| Anika Therapeutics, Inc. | 280.51M |
| Savara, Inc. | 1.105B |
| Vericel Corp. | 1.986B |
Market Cap Related Metrics
| Price | 0.2947 |
| Earnings Yield | -217.3% |